• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE ONYX RX STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE ONYX RX STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Activation, Positioning or SeparationProblem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/10/2020
Event Type  malfunction  
Manufacturer Narrative
Journal article: device profile of the resolute onyx zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy authors: moritz blum, davide cao & roxana mehran journal: expert review of medical devices year: 2020 reference: doi:10. 1080/17434440. 2020. 1736037. There is no established or suspected causal relationship between the device and the death events. Deaths are common occurrences in clinical studies, however the cause(s) of death are often not characterized or clearly associated with a particular product. Therefore, deaths will not be considered reportable unless clearly stated as being associated with a medtronic device. If information is provided in the future, a supplemental report will be issued.
 
Event Description
An article titled "device profile of the resolute onyx zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy" was submitted. The aim of the article was to review the resolute onyx device features using pre-clinical evidence and clinical studies which involved patient's being treated with resolute onyx. The review used data from several studies and registries including the bionix trial, onyx one trial, resolute onyx 2mm clinical study, hong kong resolute onyx registry, resolute onyx core trial and the kamir registry. The total of 3076 participants from these studies that had at least one resolute onyx implanted. Clinical outcomes included target lesion failure (tlf); defined as a composite of cardiac death, target vessel mi and target lesion revascularization (tlr); definite and probable stent thrombosis, late lumen loss, chronic total occlusion and in-stent restenosis. Malapposed struts at baseline and 30 days were also reported, with no stent recoil or significant late acquired malapposition indicated. The article also referred to two studies in which resolute integrity coronary drug eluting stents were used, the dutch peers study and the sort out vi study. One year follow-up outcomes for these studies included cardiac death, myocardial infarction and target vessel revascularization (tvr).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameRESOLUTE ONYX RX
Type of DeviceSTENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
 
091708734
MDR Report Key10811092
MDR Text Key219350222
Report Number9612164-2020-04324
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation
Type of Report Initial
Report Date 11/09/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received10/21/2020
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 11/09/2020 Patient Sequence Number: 1
-
-